Xencor, Inc. (XNCR)
17.02
-0.14
(-0.79%)
USD |
NASDAQ |
Dec 11, 16:00
17.02
0.00 (0.00%)
After-Hours: 20:00
Xencor Cash from Financing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Glaukos Corp. | 5.264M |
| Boston Scientific Corp. | -104.00M |
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| GT Biopharma, Inc. | 0.977M |
| Nuvalent, Inc. | 4.773M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.82M |
| Cash from Investing (Quarterly) | 14.67M |
| Free Cash Flow | -137.94M |
| Free Cash Flow Per Share (Quarterly) | -0.4166 |
| Free Cash Flow to Equity (Quarterly) | -20.45M |
| Free Cash Flow to Firm (Quarterly) | -23.34M |
| Free Cash Flow Yield | -10.97% |